summary
Introduced
03/09/2023
03/09/2023
In Committee
03/09/2023
03/09/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.
AI Summary
This bill aims to amend the Social Security Act to provide hereditary cancer genetic testing and coverage for certain cancer screenings and preventive surgeries for individuals with a history of a hereditary cancer gene mutation or a personal or family history suspicious for hereditary cancer. Specifically, it would require Medicare coverage for germline mutation testing, which is genetic testing for inherited mutations associated with increased cancer risk, and increase frequency limitations for evidence-based screenings like mammography, MRI, colonoscopy, and PSA testing for individuals with a confirmed hereditary cancer gene mutation. The bill also specifies that certain risk-reducing surgeries would be considered reasonable and necessary for the treatment of illness under Medicare.
Committee Categories
Budget and Finance
Sponsors (3)
Last Action
Read twice and referred to the Committee on Finance. (on 03/09/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/senate-bill/765/all-info |
| BillText | https://www.congress.gov/118/bills/s765/BILLS-118s765is.pdf |
Loading...